Gautam Chukka

Stock Analyst at Chardan Capital

(n/a)
n/a
Analyst rank
4
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Gautam Chukka

Adagene
Sep 10, 2026
Initiated: Buy
Price Target: $9
Current: $3.27
Upside: +175.23%
Tenax Therapeutics
Aug 11, 2026
Downgraded: Hold
Price Target: $27$5
Current: $2.13
Upside: +134.74%